Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Materia Medica Holding clinical trials
The registry lists 43 studies whose lead sponsor is Materia Medica Holding. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 10, 2026.
Keep track of what changes. Save the Materia Medica Holding studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Materia Medica Holding.
- Materia Medica Holding43 studiesSame company
Something wrong?
Focus areas
Conditions Materia Medica Holding leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 43 of 43.
- Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Bronchitis in Adult PatientsRecruitingNCT07650227Phase 3
- The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult PatientsRecruitingNCT06901297Phase 3
- Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 YearsRecruitingNCT06715891Phase 3
- Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in ChildrenRecruitingNCT07171099Phase 3
- Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy VolunteersCompletedNCT07754279Phase 1
- Clinical Trial of the Safety and Tolerability of the Drug MMH-450 in Healthy VolunteersCompletedNCT07708623Phase 1
- Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial CystitisActive, not recruitingNCT06284265Phase 3
- Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired PneumoniaCompletedNCT06263881Phase 3
- Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in OutpatientsCompletedNCT05364671Phase 3
- Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2CompletedNCT05069649Phase 3
- Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Cognitive DisordersCompletedNCT04295681Phase 3
- Prospekta in the Treatment of Cognitive, Behavioral and Psychiatric Disorders in Patients With Vascular Dementia.CompletedNCT04552041Phase 3
- Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years OldCompletedNCT04918771Phase 3
- Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia.CompletedNCT05074888Phase 3
- Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in ChildrenCompletedNCT04569357Phase 3
- Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in ChildrenCompletedNCT03159104Phase 3
- Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient AdultsSuspendedNCT04250311Phase 3
- Efficacy and Safety of Tenoten in the Treatment of Children With Anxiety DisordersCompletedNCT05605938Phase 4
- Clinical Trial of Efficacy and Safety of Kolofort in Functional Dyspepsia PatientsCompletedNCT03119766Phase 4
- Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral InfectionCompletedNCT04244084Phase 3
- Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in ChildrenCompletedNCT03039621Phase 4
- Clinical Trial of Safety and Efficacy of New Dosage Schedule for Dietressa Drug in Treatment of Obese PatientsCompletedNCT01570829Phase 3
- Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral AtherosclerosisCompletedNCT03485495Phase 4
- Study on Safety and Effectiveness of Ergoferon in the Treatment of Flu / ARVI in Outpatients.CompletedNCT04413929
- Study on Efficacy and Safety of Divaza in Patients With Chronic Cerebral Ischemia and Cognitive DisordersCompletedNCT04370028
- Clinical Trial of Efficacy and Safety of MMH-MAP in the Treatment of Mild Cognitive Impairment in Early Recovery Stage After Ischemic StrokeCompletedNCT03815292Phase 3
- Clinical Trial of Efficacy and Safety of Subetta in the Treatment of Impaired Glucose ToleranceCompletedNCT03725033Phase 3
- Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in AdultsCompletedNCT01765920Phase 3
- Tenoten® in the Treatment of Somatoform, Stress-related and Other Neurotic DisordersCompletedNCT03036293Phase 4
- Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT03159091Phase 4
- Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in ChildrenCompletedNCT03039699Phase 4
- Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral InfectionsCompletedNCT03707912Phase 4
- Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVICompletedNCT03301155Phase 4
- Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of InfluenzaCompletedNCT01850446Phase 4
- Efficacy and Safety Clinical Trial of Tenoten for Children Liquid Dosage Form Therapy in Infants With Sequelae of Perinatal Brain InjuryCompletedNCT03159611Phase 3
- Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in ChildrenCompletedNCT02072174Phase 4
- Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes MellitusCompletedNCT01868646Phase 4
- Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes MellitusCompletedNCT01868594Phase 4
- Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in ChildrenCompletedNCT01843842Phase 3
- Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of ProgressionCompletedNCT01716104Phase 3
- Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory InfectionsCompletedNCT03162458Phase 3
- Clinical Trial of Safety and Efficacy of Various Dosage Schedules for Dietressa Drug in Treatment of Obese PatientsCompletedNCT01535014Phase 3
- Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of InfluenzaCompletedNCT01804946Phase 4